Statins and the Prevention of Coronary Heart Disease: Striking a Balance That is Desirable, Affordable, and Achievable

Overview

Journal Br J Gen Pract

Specialty Public Health

Date 2000 Oct 29

PMID 11050781

Authors

L D Ritchie

Affiliations

Soon will be listed here.

References

Kernick D . Costing interventions in primary care. Fam Pract. 2000; 17(1):66-70. DOI: 10.1093/fampra/17.1.66. View

Yudkin J, Chaturvedi N . Developing risk stratification charts for diabetic and nondiabetic subjects. Diabet Med. 1999; 16(3):219-27. DOI: 10.1046/j.1464-5491.1999.00026.x. View

Wallis E, Ramsay L, Ul Haq I, Ghahramani P, Jackson P, Rowland-Yeo K . Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population. BMJ. 2000; 320(7236):671-6. PMC: 27307. DOI: 10.1136/bmj.320.7236.671. View

Isles C, Ritchie L, Murchie P, Norrie J . Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods. BMJ. 2000; 320(7236):690-1. PMC: 27313. DOI: 10.1136/bmj.320.7236.690. View

Fenwick E, Briggs A, Hawke C . Management of urinary tract infection in general practice: a cost-effectiveness analysis. Br J Gen Pract. 2000; 50(457):635-9. PMC: 1313774. View

Anggard E, Land J, Lenihan C, Packard C, Percy M, Ritchie L . Prevention of cardiovascular disease in general practice: a proposed model. Br Med J (Clin Res Ed). 1986; 293(6540):177-80. PMC: 1340912. DOI: 10.1136/bmj.293.6540.177. View

Anderson K, Odell P, Wilson P, Kannel W . Cardiovascular disease risk profiles. Am Heart J. 1991; 121(1 Pt 2):293-8. DOI: 10.1016/0002-8703(91)90861-b. View

Jackson R, Barham P, Bills J, Birch T, McLennan L, Macmahon S . Management of raised blood pressure in New Zealand: a discussion document. BMJ. 1993; 307(6896):107-10. PMC: 1693500. DOI: 10.1136/bmj.307.6896.107. View

Robinson R . Cost-utility analysis. BMJ. 1993; 307(6908):859-62. PMC: 1678861. DOI: 10.1136/bmj.307.6908.859. View

10.

Robinson R . Cost-effectiveness analysis. BMJ. 1993; 307(6907):793-5. PMC: 1696433. DOI: 10.1136/bmj.307.6907.793. View

11.

Kinosian B, GLICK H, Garland G . Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994; 121(9):641-7. DOI: 10.7326/0003-4819-121-9-199411010-00002. View

12.

Cupples M, McKnight A . Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ. 1994; 309(6960):993-6. PMC: 2541257. DOI: 10.1136/bmj.309.6960.993. View

13.

Shepherd J, Cobbe S, Ford I, Isles C, LORIMER A, Macfarlane P . Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995; 333(20):1301-7. DOI: 10.1056/NEJM199511163332001. View

14.

Haq I, Jackson P, Yeo W, Ramsay L . Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet. 1995; 346(8988):1467-71. DOI: 10.1016/s0140-6736(95)92477-9. View

15.

Ramsay L, Haq I, Jackson P, Yeo W, Pickin D, Payne J . Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet. 1996; 348(9024):387-8. DOI: 10.1016/s0140-6736(96)05516-x. View

16.

Sacks F, Pfeffer M, Moye L, Rouleau J, Rutherford J, Cole T . The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996; 335(14):1001-9. DOI: 10.1056/NEJM199610033351401. View

17.

Ul Haq I, Ramsay L, Pickin D, Yeo W, Jackson P, Payne J . Lipid-lowering for prevention of coronary heart disease: what policy now?. Clin Sci (Lond). 1996; 91(4):399-413. DOI: 10.1042/cs0910399. View

18.

Tunstall-Pedoe H, Woodward M, Tavendale R, Abrook R, McCluskey M . Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study. BMJ. 1997; 315(7110):722-9. PMC: 2127508. DOI: 10.1136/bmj.315.7110.722. View

19.

Freemantle N, Barbour R, Johnson R, Marchment M, Kennedy A . The use of statins: a case of misleading priorities?. BMJ. 1997; 315(7112):826-8. PMC: 2127566. DOI: 10.1136/bmj.315.7112.826. View

20.

Bucher H, Griffith L, Guyatt G . Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med. 1998; 128(2):89-95. DOI: 10.7326/0003-4819-128-2-199801150-00002. View